EPA TRI Facility · Chemicals

Mallinckrodt Pharmaceuticals

Raleigh, NC · Parent: Meh Inc

Total releases
501.8K lbs
Chemicals reported
4
Carcinogens
2
Primary pathway
Off-site Transfers
Verify at EPA TRI →

Mallinckrodt Pharmaceuticals has reported 501.8K lbs of toxic releases across 4 chemicals to the EPA Toxic Release Inventory, based on annual facility disclosures from 2019 through 2023. Of the chemicals reported, 2 are classified as carcinogens, representing 50% of the facility's chemical profile. The facility operates in the Chemicals sector. The primary release pathway is off-site transfers, accounting for 35% of total releases. All release data shown below is self-reported to the EPA under the Emergency Planning and Community Right-to-Know Act (EPCRA) Section 313.

#1,954 of 25,902 TRI facilities nationwide by total reported releases - among the top 7.5% of reporting sites by volume. Ranking reflects reported pounds, not toxicity or health risk.

Mallinckrodt Pharmaceuticals files annual Form R disclosures to the EPA Toxics Release Inventory under EPCRA Section 313, classified under NAICS 325411 (Chemicals). Across 5 years of records spanning 2019–2023, the site has disclosed 501.8K lbs in cumulative toxic releases across 4 distinct chemicals, 2 of which (50%) carry a carcinogenic classification.

The dominant release pathway is off-site transfers at 173.9K lbs (34.7% of total volume), followed by water discharges at 26.7%. Between 2019 and 2023, reported totals decreased by 13% - from 100.0K lbs to 87.4K lbs. The facility is operated under parent company Meh Inc.

TRI Form R values are self-reported estimates, not measured stack emissions, and treat every pound of reported chemical equally regardless of toxicity. Inclusion in the TRI database does not establish a health risk to nearby residents; it documents the annual reporting record that Mallinckrodt Pharmaceuticals has filed with the EPA under federal community right-to-know requirements.

Quick Facts

Industry
Chemicals
NAICS Code
325411
Total Releases
501.8K lbs
Chemicals Reported
4
Latest Report Year
2023

Compare this facility

See how Mallinckrodt Pharmaceuticals stacks up against nearby facilities and the typical reporter.

Total reported releases
Mallinckrodt Pharmaceuticals
501.8K lbs
Befesa Zinc Metal LLC
43.1M lbs

99% less than the comparison

Chemicals reported
Mallinckrodt Pharmaceuticals
4
Befesa Zinc Metal LLC
4

About the same as the comparison

Comparison reflects reported pounds and chemical counts, not toxicity or health risk. Averages cover facilities reporting any release.

How does this facility release toxic chemicals?

How Mallinckrodt Pharmaceuticals releases toxic chemicals into the environment. Total: 501.8K lbs.

Off-site Transfers 173.9K lbs (34.7%)
Water Discharges 134.0K lbs (26.7%)
Land Disposal 107.5K lbs (21.4%)
Air Releases 86.4K lbs (17.2%)
View 5-Year Emissions Trend →

Emissions Trend Summary

From 2019 to 2023, total releases decreased by 13% (100.0K lbs to 87.4K lbs).

Reported total releases by year

Mallinckrodt Pharmaceuticals - annual TRI totals

million lbs

What this shows Year-over-year reported totals. TRI figures are self-reported estimates and can swing with production levels, waste-rock handling and reporting changes, not only with emissions controls.

Source EPA Toxics Release Inventory (TRI)
Year Total Chemicals
2019 100.0K lbs 4
2020 157.9K lbs 4
2021 63.3K lbs 4
2022 93.1K lbs 4
2023 87.4K lbs 4

Chemical Releases

Aggregated across all reporting years (2019–2023). 2 of 4 chemicals are carcinogens. Sorted by total release volume.

Chemical Total Flags
Nitrate compounds (water dissociable; reportable only when in aqueous solution) 397.2K lbs -
Aniline 53.2K lbs Carcinogen
Nitrobenzene 26.5K lbs Carcinogen
Ammonia 24.9K lbs -

Location

Coordinates
35.8988, -78.5586
ZIP Code
27616
EPA Facility ID
27604MLLNC8801N

About TRI Data

Data as of 2023 reporting year. Source: U.S. Environmental Protection Agency (EPA) Toxic Release Inventory.

Data comes from the EPA Toxic Release Inventory (TRI) program. Facilities that manufacture, process, or otherwise use listed toxic chemicals above threshold amounts are required to report annually to the EPA.

Release quantities are self-reported by the facility and may represent estimates rather than exact measurements. "Total releases" includes releases to air, water, land, and off-site transfers for disposal. Quantities shown here are aggregated across all available reporting years.

PlainEnviro presents this data without advocacy framing. The presence of a facility in the TRI database does not by itself indicate a health risk. For site-specific health questions, consult your local environmental or health agency.

Frequently Asked Questions

What chemicals does Mallinckrodt Pharmaceuticals release?
Mallinckrodt Pharmaceuticals has reported releases of 4 chemicals to the EPA Toxic Release Inventory, totaling 501.8K lbs. 2 of these (50%) are classified as carcinogens.
What industry is Mallinckrodt Pharmaceuticals in?
Mallinckrodt Pharmaceuticals is classified under the "Chemicals" industry (NAICS code 325411), located in Raleigh, NC.
How long has Mallinckrodt Pharmaceuticals reported to the TRI?
Mallinckrodt Pharmaceuticals has EPA Toxic Release Inventory data spanning 5 years, from 2019 to 2023.
How does Mallinckrodt Pharmaceuticals release toxic chemicals?
The primary release pathway for Mallinckrodt Pharmaceuticals is off-site transfers, accounting for 34.7% of total releases (173.9K lbs). Secondary pathway: water discharges (26.7%).
Are emissions from Mallinckrodt Pharmaceuticals increasing or decreasing?
From 2019 to 2023, total releases decreased by 13%, from 100.0K lbs to 87.4K lbs.
Is Mallinckrodt Pharmaceuticals a health risk?
The presence of a facility in the TRI database does not by itself indicate a health risk. Release quantities are self-reported estimates. For site-specific health questions, consult your local environmental or health agency.
Does Mallinckrodt Pharmaceuticals release carcinogens?
Yes, Mallinckrodt Pharmaceuticals reports 2 chemicals classified as carcinogens, representing 50% of all chemicals reported by this facility. Carcinogen classification is based on EPA and IARC assessments.

What to do with this facility's data

Use this facility profile as a starting point, then check how it compares.

  • See whether releases reported by Mallinckrodt Pharmaceuticals are rising or falling over time. View trends
  • This facility ranks #1,954 of 25,902 TRI facilities nationwide by total reported releases - among the top 7.5% of reporting sites by volume. Ranking reflects reported pounds, not toxicity or health risk. See the full rankings
  • Check North Carolina's statewide profile for the full picture: total facilities, water systems, and Superfund sites. View North Carolina profile

TRI release totals are self-reported estimates submitted to the EPA, not independently measured stack emissions; a high rank reflects reported volume, not necessarily local health risk.

Related

Sources & how this page was built

Every figure on this page traces to public, federal-government data on Mallinckrodt Pharmaceuticals. The records below are the primary sources; our methodology explains how they are joined, computed, and verified.

Retrieved and formatted by PlainEnviro Editorial. TRI release totals are self-reported estimates, not measured stack emissions.

According to the U.S. Environmental Protection Agency, the Toxics Release Inventory has required annual industrial disclosure since its creation under the Emergency Planning and Community Right-to-Know Act in October 1986, and this facility's record is drawn from PlainEnviro's database of more than 25,000 EPA-tracked facilities through the 2023 reporting year; see our methodology for full source citations and refresh cadence.